202 related articles for article (PubMed ID: 399644)
1. Antiplatelet agents: a review.
Gantmacher ML
J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
[No Abstract] [Full Text] [Related]
2. [Treatment with antiplatelet drugs. Current status of knowledge].
Dettori AG; Pini M; Quintavalla R
Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
[No Abstract] [Full Text] [Related]
3. Platelet suppressive therapy.
Turpie AG; Hirsh J
Br Med Bull; 1978 May; 34(2):183-90. PubMed ID: 350343
[No Abstract] [Full Text] [Related]
4. Use of common antiplatelet drugs for vascular diseases.
Pagano T; Nair CK; Sketch MH
Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278
[No Abstract] [Full Text] [Related]
5. The current status of platelet suppressive drugs in the treatment of thrombosis.
Hirsh J; Gent M; Genton E
Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
[No Abstract] [Full Text] [Related]
6. Antiplatelet therapy.
Turpie AG
Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
[No Abstract] [Full Text] [Related]
7. Antiplatelet agents in coronary disease: are they of prophylactic value?
Verstraete M
Drugs; 1978 Jun; 15(6):464-71. PubMed ID: 657992
[No Abstract] [Full Text] [Related]
8. Platelet function inhibitors: their clinical use.
Fuster V; Didisheim P
Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
[No Abstract] [Full Text] [Related]
9. [Correction of thrombophilia].
Caruzzo C; Marcolongo M; Arpino E; Di Summa M
Minerva Cardioangiol; 1981; 29(1-2):13-8. PubMed ID: 6112717
[No Abstract] [Full Text] [Related]
10. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Harker LA; Hirsh J; Gent M; Genton E
Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
[No Abstract] [Full Text] [Related]
11. Platelet inhibitors in the treatment of thrombosis.
Hirsh J
Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
[No Abstract] [Full Text] [Related]
12. Drug therapy: antiplatelet therapy (second of two parts).
Weiss HJ
N Engl J Med; 1978 Jun; 298(25):1403-6. PubMed ID: 349388
[No Abstract] [Full Text] [Related]
13. Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Verstraete M
Acta Clin Belg; 1976; 31(4):229-32. PubMed ID: 1087523
[No Abstract] [Full Text] [Related]
14. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Genton E; Gent M; Hirsh J; Harker LA
N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
[No Abstract] [Full Text] [Related]
15. A critical appraisal of the clinical efficiency of anti-platelet drugs.
Lecompte T; Samama M
Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
[No Abstract] [Full Text] [Related]
16. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Hirsh J
Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
[TBL] [Abstract][Full Text] [Related]
17. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
18. Platelets and antiplatelet therapy in ischemic heart disease.
Frishman WH; Miller KP
Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576
[No Abstract] [Full Text] [Related]
19. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Genton E
Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
[No Abstract] [Full Text] [Related]
20. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
